These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 30767203)

  • 1. NLRC3 inhibits MCT-induced pulmonary hypertension in rats via attenuating PI3K activation.
    Zha LH; Zhou J; Li TZ; Luo H; Zhang MQ; Li S; Yu ZX
    J Cell Physiol; 2019 Sep; 234(9):15963-15976. PubMed ID: 30767203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NLRC3 inhibits PDGF-induced PASMCs proliferation via PI3K-mTOR pathway.
    Zha LH; Zhou J; Tan Y; Guo S; Zhang MQ; Li S; Yan P; Yu ZX
    J Cell Physiol; 2020 Dec; 235(12):9557-9567. PubMed ID: 32383265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ligustrazine Suppresses Platelet-Derived Growth Factor-BB-Induced Pulmonary Artery Smooth Muscle Cell Proliferation and Inflammation by Regulating the PI3K/AKT Signaling Pathway.
    Huang H; Kong L; Luan S; Qi C; Wu F
    Am J Chin Med; 2021; 49(2):437-459. PubMed ID: 33622214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Docosahexaenoic acid inhibits monocrotaline-induced pulmonary hypertension via attenuating endoplasmic reticulum stress and inflammation.
    Chen R; Zhong W; Shao C; Liu P; Wang C; Wang Z; Jiang M; Lu Y; Yan J
    Am J Physiol Lung Cell Mol Physiol; 2018 Feb; 314(2):L243-L255. PubMed ID: 29097423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Icotinib Attenuates Monocrotaline-Induced Pulmonary Hypertension by Preventing Pulmonary Arterial Smooth Muscle Cell Dysfunction.
    Peng LY; Yu M; Yang MX; Liu P; Zhou H; Huang W; Kong H; Xie WP
    Am J Hypertens; 2020 Aug; 33(8):775-783. PubMed ID: 32301965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LncPTSR Triggers Vascular Remodeling in Pulmonary Hypertension by Regulating [Ca
    Deng L; Chen J; Chen B; Wang T; Yang L; Liao J; Yi J; Chen Y; Wang J; Linneman J; Niu Y; Gou D
    Am J Respir Cell Mol Biol; 2022 May; 66(5):524-538. PubMed ID: 35148256
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isoquercitrin protects against pulmonary hypertension via inhibiting PASMCs proliferation.
    Zhang Y; Cui Y; Deng W; Wang H; Qin W; Huang C; Li C; Zhang J; Guo Y; Wu D; Guo H
    Clin Exp Pharmacol Physiol; 2017 Mar; 44(3):362-370. PubMed ID: 27873355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. β-sitosterol alleviates pulmonary arterial hypertension by altering smooth muscle cell phenotype and DNA damage/cGAS/STING signaling.
    Li J; Meng ZY; Wen H; Lu CH; Qin Y; Xie YM; Chen Q; Lv JH; Huang F; Zeng ZY
    Phytomedicine; 2024 Dec; 135():156030. PubMed ID: 39265206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glycogen synthase kinase 3beta contributes to proliferation of arterial smooth muscle cells in pulmonary hypertension.
    Sklepkiewicz P; Schermuly RT; Tian X; Ghofrani HA; Weissmann N; Sedding D; Kashour T; Seeger W; Grimminger F; Pullamsetti SS
    PLoS One; 2011 Apr; 6(4):e18883. PubMed ID: 21533110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL; Wu ZJ; Liu XR; Gui LX; Wang RX; Lin MJ
    Cell Physiol Biochem; 2018; 49(1):172-189. PubMed ID: 30134231
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PAR-2 inhibition reverses experimental pulmonary hypertension.
    Kwapiszewska G; Markart P; Dahal BK; Kojonazarov B; Marsh LM; Schermuly RT; Taube C; Meinhardt A; Ghofrani HA; Steinhoff M; Seeger W; Preissner KT; Olschewski A; Weissmann N; Wygrecka M
    Circ Res; 2012 Apr; 110(9):1179-91. PubMed ID: 22461388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of Shp2 ameliorates monocrotaline-induced pulmonary arterial hypertension in rats.
    Cheng Y; Yu M; Xu J; He M; Wang H; Kong H; Xie W
    BMC Pulm Med; 2018 Aug; 18(1):130. PubMed ID: 30086741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of Src tyrosine kinases in experimental pulmonary hypertension.
    Pullamsetti SS; Berghausen EM; Dabral S; Tretyn A; Butrous E; Savai R; Butrous G; Dahal BK; Brandes RP; Ghofrani HA; Weissmann N; Grimminger F; Seeger W; Rosenkranz S; Schermuly RT
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1354-65. PubMed ID: 22516066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The zinc transporter ZIP12 regulates monocrotaline-induced proliferation and migration of pulmonary arterial smooth muscle cells via the AKT/ERK signaling pathways.
    Ye C; Lian G; Wang T; Chen A; Chen W; Gong J; Luo L; Wang H; Xie L
    BMC Pulm Med; 2022 Mar; 22(1):111. PubMed ID: 35346134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PDGF Promotes the Warburg Effect in Pulmonary Arterial Smooth Muscle Cells via Activation of the PI3K/AKT/mTOR/HIF-1α Signaling Pathway.
    Xiao Y; Peng H; Hong C; Chen Z; Deng X; Wang A; Yang F; Yang L; Chen C; Qin X
    Cell Physiol Biochem; 2017; 42(4):1603-1613. PubMed ID: 28738389
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulatory effects of Prohibitin 1 on proliferation and apoptosis of pulmonary arterial smooth muscle cells in monocrotaline-induced PAH rats.
    Cao YY; Ba HX; Li Y; Tang SY; Luo ZQ; Li XH
    Life Sci; 2020 Jun; 250():117548. PubMed ID: 32173312
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Isorhynchophylline protects against pulmonary arterial hypertension and suppresses PASMCs proliferation.
    Guo H; Zhang X; Cui Y; Deng W; Xu D; Han H; Wang H; Chen Y; Li Y; Wu D
    Biochem Biophys Res Commun; 2014 Jul; 450(1):729-34. PubMed ID: 24950404
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of KIR2.1 decreases pulmonary artery smooth muscle cell proliferation and migration.
    Cao N; Aikeremu N; Shi WY; Tang XC; Gao RJ; Kong LJ; Zhang JR; Qin WJ; Zhang AM; Ma KT; Li L; Si JQ
    Int J Mol Med; 2022 Sep; 50(3):. PubMed ID: 35856410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol reverses monocrotaline-induced pulmonary vascular and cardiac dysfunction: a potential role for atrogin-1 in smooth muscle.
    Paffett ML; Lucas SN; Campen MJ
    Vascul Pharmacol; 2012; 56(1-2):64-73. PubMed ID: 22146233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The protective role of EP300 in monocrotaline-induced pulmonary hypertension.
    Yang L; Tian J; Wang J; Zeng J; Wang T; Lin B; Linneman J; Li L; Niu Y; Gou D; Zhang Y
    Front Cardiovasc Med; 2023; 10():1037217. PubMed ID: 36910531
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.